Pharmaceutical care program for patients with reactive airways disease

Effects of computerized guidelines for managing heart disease in primary care

“…In addition, patient medication compliance as measured by the Inui measure 45 (mean compliance = 87%) and the Morisky instrument 46 (mean score = 0.79) was not different between study groups ( P > .69). Nor were there intergroup differences in the medication possession ratio ( P > .10) 44,48 . Controlling for satisfaction at baseline, there were no differences between patient groups in satisfaction with the physicians ( P > .5) or pharmacists ( P > .4).…”

“…We assessed satisfaction with physicians with the questionnaire developed by the American Board of Internal Medicine (ABIM), 42 which had also been locally validated 43 . Satisfaction with pharmacists was assessed using a questionnaire we created and validated 44 . Medication compliance was assessed with instruments developed by Inui 45 and Morisky 46 and by calculating the medication possession ratio, 47 also locally validated, 48 which uses computer‐stored refill information.…”

Can Computer‐Generated Evidence‐Based Care Suggestions Enhance Evidence‐Based Management of Asthma and Chronic Obstructive Pulmonary Disease? A Randomized, Controlled Trial

“…We also administered the American Board of Internal Medicine's patient satisfaction questionnaire (Webster 1988), a measure of physicians' communication abilities that had been previously validated in this practice (Dexter et al 1996). We assessed pharmacy satisfaction with a locally developed questionnaire (Weinberger et al 2001). Medication adherence was assessed using surveys developed by Inui, Carter, and Pecoraro (1981) and Morisky, Green, and Levine (1986).…”

What works for whom in pharmacist-led smoking cessation support: realist review

“…These consisted of the following (some papers described more than one study type):12 systematic reviews (5 of RCTs of pharmacist-led behavioural interventions for smoking [15–19], 1 of process elements of such interventions [20], 3 of pharmacist-led behavioural interventions other than smoking cessation [15, 19, 21], 1 of the scope of pharmacy practice [4], 1 of pharmacists’ perceptions [13], and 1 of qualitative studies of the patient experience [22]);6 reviews not described as ‘systematic’, of pharmacy business models, pharmacist scope of practice, pharmacist training programmes or the process elements of RCTs [2, 23–27];18 RCTs, of which 14 related to smoking cessation [28–41] and 4 to other behavioural interventions [42–45];1 cost-effectiveness study linked to a RCT [40];1 paper describing additional process detail on a RCT [46];12 evaluations of pharmacist training courses, using either pre-post classroom assessments or ‘mystery shopper’ assessments of performance in practice, comprising 2 linked to RCTs [28, 29] and 10 before and after studies [47–56];7 papers reporting quantitative surveys (6 of pharmacists [57–62] and 4 of service users [57, 58, 63, 64]);6 papers describing qualitative studies, 5 based on semi-structured interviews (3 of pharmacists [3, 65, 66], 1 of pharmacy owners [67], 2 of service users [3, 65], 1 of researchers [68]) and 1 a focus group study of service users [69];2 in-depth case studies [70, 71];2 business models [67, 72];1 paper describing the development of a complex intervention [73]. …”